The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
Abstract
Nasopharyngeal carcinoma of the undifferentiated subtype is endemic to southern China, and patient prognosis has improved significantly over the past three decades because of advances in disease management, diagnostic imaging, radiotherapy technology, and broader application of systemic therapy. Despite the excellent local control with modern radiotherapy, distant failure remains a key challenge. Advances in molecular technology have helped to decipher the molecular pathogenesis of nasopharyngeal carcinoma as well as its etiologic association with the Epstein-Barr virus. This in turn has led to the discovery of novel biomarkers and drug targets, rendering this cancer site a current focus for new drug development. This article reviews and appraises the key literature on the current management of nasopharyngeal carcinoma and future directions in clinical research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Al-Sarraf, M., LeBlanc, M., Giri, P. G., Fu, K. K., Cooper, J., Vuong, T., Forastiere, A. A., Adams, G., Sakr, W. A., Schuller, D. E., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1310 · Cited by 2,222
Chen, B. J., Chapuy, B., Ouyang, J., Sun, H. H., Roemer, M. G. M., Xu, M. L., Yu, H., Fletcher, C. D. M., Freeman, G. J., Shipp, M. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0855 · Cited by 843
(15031584), Y. M. D. L., Chan, L. Y. S., Lo, K. W., Leung, S. F., Zhang, J., Chan, A. T. �., Lee, J. C., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (1999) · PubMed · Cited by 777
Self-citationLin, J.-C., Jan, J.-S., Hsu, C.-Y., Liang, W.-M., Jiang, R.-S., & Wang, W.-Y. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.158 · Cited by 762
Pow, E. H. N., Kwong, D. L. W., McMillan, A. S., Wong, M. C. M., Sham, J. S. T., Leung, L. H. T., & Leung, W. K. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.06.013 · Cited by 737
Lee, N., Harris, J., Garden, A. S., Straube, W., Glisson, B., Xia, P., Bosch, W., Morrison, W. H., Quivey, J., Thorstad, W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9109 · Cited by 706
Wee, J., Tan, E. H., Tai, B. C., Wong, H. B., Leong, S. S., Tan, T., Chua, E. T., Yang, E., Lee, K. M., Fong, K. W., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.790 · Cited by 650
Peng, G., Wang, T., Yang, K.-Y., Zhang, S., Zhang, T., Li, Q., Han, J., & Wu, G. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.08.013 · Cited by 624
Lai, S.-Z., Li, W.-F., Chen, L., Luo, W., Chen, Y.-Y., Liu, L.-Z., Sun, Y., Lin, A.-H., Liu, M.-Z., & Ma, J. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.03.024 · Cited by 611
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
Lui, V. W. Y., Hedberg, M. L., Li, H., Vangara, B. S., Pendleton, K., Zeng, Y., Lu, Y., Zhang, Q., Du, Y., Gilbert, B. R., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0103 · Cited by 589
Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience
Lee, A. W. M., Sze, W. M., Au, J. S. K., Leung, S. F., Leung, T. W., Chua, D. T. T., Zee, B. C. Y., Law, S. C. K., Teo, P. M. L., Tung, S. Y., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.07.702 · Cited by 587
Self-citationChen, L., Hu, C.-S., Chen, X.-Z., Hu, G.-Q., Cheng, Z.-B., Sun, Y., Li, W.-X., Chen, Y.-Y., Xie, F.-Y., Liang, S.-B., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70320-5 · Cited by 558
Hui, E. P., Ma, B. B., Leung, S. F., King, A. D., Mo, F., Kam, M. K., Yu, B. K., Chiu, S. K., Kwan, W. H., Ho, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1545 · Cited by 523
Self-citationChan, A. T. C., Teo, P. M. L., Ngan, R. K., Leung, T. W., Lau, W. H., Zee, B., Leung, S. F., Cheung, F. Y., Yeo, W., Yiu, H. H., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.149 · Cited by 474
Self-citationChan, A. T. �., Lo, Y. M. D., Zee, B., Chan, L. Y. S., Ma, B. B. Y., Leung, S.-F., Mo, F., Lai, M., Ho, S., Huang, D. P., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.21.1614 · Cited by 452
Self-citationLee, A. W. M., Lau, W. H., Tung, S. Y., Chua, D. T. T., Chappell, R., Xu, L., Siu, L., Sze, W. M., Leung, T. W., Sham, J. S. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.7542 · Cited by 449
Self-citationFang, W., Zhang, J., Hong, S., Zhan, J., Chen, N., Qin, T., Tang, Y., Zhang, Y., Kang, S., Zhou, T., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2608 · Cited by 398
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus
Cheung, S. T., Huang, D. P., Hui, A. B. Y., Lo, K. W., Ko, C. W., Tsang, Y. S., Wong, N., Whitney, B. M., & Lee, J. C. K. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990924)83:1<121::aid-ijc21>3.0.co;2-f · Cited by 395
The genomic landscape of nasopharyngeal carcinoma
Lin, D.-C., Meng, X., Hazawa, M., Nagata, Y., Varela, A. M., Xu, L., Sato, Y., Liu, L.-Z., Ding, L.-W., Sharma, A., et al. (2014) · Nature Genetics · doi:10.1038/ng.3006 · Cited by 366
Lee, N. Y., Zhang, Q., Pfister, D. G., Kim, J., Garden, A. S., Mechalakos, J., Hu, K., Le, Q. T., Colevas, A. D., Glisson, B. S., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70303-5 · Cited by 359
Self-citationTreatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes
Straathof, K. C. M., Bollard, C. M., Popat, U., Huls, M. H., Lopez, T., Morriss, M. C., Gresik, M. V., Gee, A. P., Russell, H. V., Brenner, M. K., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2975 · Cited by 353
Lo, Y. M. D., Chan, A. T. �., Chan, L. Y. S., Leung, S. F., Lam, C., Huang, D. P., & Johnson, P. J. (2000) · PubMed · Cited by 341
Self-citationChen, Q.-Y., Wen, Y.-F., Guo, L., Liu, H., Huang, P.-Y., Mo, H.-Y., Li, N.-W., Xiang, Y.-Q., Luo, D.-H., Qiu, F., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr432 · Cited by 339
Lee, A. W. M., Tung, S. Y., Chua, D. T. T., Ngan, R. K. C., Chappell, R., Tung, R., Siu, L., Ng, W. T., Sze, W. K., Au, G. K. H., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq258 · Cited by 318
Self-citationCurrent Management of Nasopharyngeal Cancer
Lee, A. W. M., Lin, J. C., & Ng, W. T. (2012) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2012.03.008 · Cited by 294
Self-citationPrognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis
Liu, N., Chen, N.-Y., Cui, R.-X., Li, W.-F., Li, Y., Wei, R.-R., Zhang, M.-Y., Sun, Y., Huang, B.-J., Chen, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70102-x · Cited by 293
Comoli, P., Pedrazzoli, P., Maccario, R., Basso, S., Carminati, O., Labirio, M., Schiavo, R., Secondino, S., Frasson, C., Perotti, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.6195 · Cited by 289
Genetic and epigenetic changes in nasopharyngeal carcinoma
Lo, K.-W., & Huang, D. P. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044579x02000883 · Cited by 269
Fountzilas, G., Ciuleanu, E., Bobos, M., Kalogera-Fountzila, A., Eleftheraki, A. G., Karayannopoulou, G., Zaramboukas, T., Nikolaou, A., Markou, K., Resiga, L., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr116 · Cited by 249
Establishment and characterization of three transplantable EBV‐containing nasopharyngeal carcinomas
Busson, P., Ganem, G., Flores, P., Mugneret, F., Clausse, B., Caillou, B., Braham, K., Wakasugi, H., Lipinski, M., & Tursz, T. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420422 · Cited by 221
Lo, K.-W., Chung, G. T.-Y., & To, K.-F. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.011 · Cited by 220
Lin, C. S., Lo, W.-F., Lee, T.-H., Ren, Y. L., Hwang, S., Cheng, Y.-F., Chen, C., Chang, Y.-S., Lee, S. P., Rickinson, A. B., et al. (2002) · PubMed · Cited by 220
Hui, E. P., Taylor, G. S., Jia, H., Ma, B. B. Y., Chan, S. L., Ho, R., Wong, W.-L., Wilson, S., Johnson, B. F., Edwards, C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2448 · Cited by 207
Self-citationChen, Y., Sun, Y., Liang, S., Zong, J., Li, W., Chen, M., Chen, L., Mao, Y., Tang, L., Guo, Y., et al. (2013) · Cancer · doi:10.1002/cncr.28049 · Cited by 166
Hsu, M.-C., Hsiao, J., Chang, K., Wu, Y.-H., Su, I., Jin, Y., & Chang, Y. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.130 · Cited by 163
Leung, S., Chan, A. T. C., Zee, B., Ma, B., Chan, L. Y. S., Johnson, P. J., & Dennis Lo, Y. M. (2003) · Cancer · doi:10.1002/cncr.11496 · Cited by 161
Self-citationChia, W. K., Wang, W.-W., Teo, M. C. C., Tai, W., Lim, W., Tan, E. H., Leong, S. S., Sun, L., Chen, J. J., Gottschalk, S. M., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr341 · Cited by 147
Eight-Signature Classifier for Prediction of Nasopharyngeal Carcinoma Survival
Wang, H., Sun, B.-Y., Zhu, Z.-H., Chang, E. T., To, K., Hwang, J. S. G., Jiang, H., Kam, M. K. M., Chen, G., Cheah, S.-L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7741 · Cited by 142
Self-citationHui, E. P., Ma, B. B. Y., King, A. D., Mo, F. K. F., Chan, S. L., Kam, M. K. M., Loong, H. H.-F., Ahuja, A. T., Zee, B. C.-Y., & Chan, A. T. �. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq629 · Cited by 128
Self-citationA Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma
Lim, W., Ng, Q., Ivy, P. S., Leong, S. S., Singh, O., Chowbay, B., Gao, F., Thng, C. H., Goh, B.-C., Tan, D. S.-W., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3409 · Cited by 122
Authentication of nasopharyngeal carcinoma tumor lines
Chan, S. Y., Choy, K., Tsao, S., Tao, Q., Tang, T., Chung, G. T., & Lo, K. (2008) · International Journal of Cancer · doi:10.1002/ijc.23374 · Cited by 119
Strong, M. J., Baddoo, M., Nanbo, A., Xu, M., Puetter, A., & Lin, Z. N. (2014) · Journal of Virology · doi:10.1128/jvi.01457-14 · Cited by 109
Cytogenetics of undifferentiated nasopharyngeal carcinoma xenografts from southern chinese
Huang, D. P., HO, J. H. C., Chan, W.-Y., Lau, W. H., & Lui, M.-T. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430535 · Cited by 102
Wan, X., Li, W., Li, H., Dong, M., Lin, Q., Ma, X.-K., Huang, P., Wen, J.-Y., Li, X., Chen, J., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.03.008 · Cited by 99
Li, J., Zeng, X., Mo, H., Rolén, U., Gao, Y.-F., Zhang, X., Chen, Q.-Y., Zhang, L., Zeng, M., Li, M., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001122 · Cited by 96
Khanna, R., Moss, D. J., & Gandhi, M. K. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0107 · Cited by 64
Yang, F., Qian, X.-J., Qin, W., Deng, R., Wu, X.-Q., Qin, J., Feng, G., & Zhu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059879 · Cited by 55
Gullo, C. A., Low, W., & Teoh, G. (2008) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v37n9p769 · Cited by 54
Yen, R., Chen, T. H.-H., Ting, L., Tzen, K., Pan, M.-H., & Hong, R. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1837-5 · Cited by 49
Nasopharyngeal carcinoma and the EBV-specific T cell response: prospects for immunotherapy
Lee, S. P. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00089-5 · Cited by 36
Preclinical evaluation of the mTOR–PI3K inhibitor BEZ235 in nasopharyngeal cancer models
Ma, B. B. Y., Lui, V. W. Y., Hui, C. W. C., Lau, C. P. Y., Wong, C. H., Hui, E. P., Ng, M. H. L., Cheng, S. H., Tsao, S. W., Tsang, C., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.007 · Cited by 33
Self-citationEpstein-Barr Virus and the Pathogenesis of Nasopharyngeal Carcinomas
Gourzonès, C., Busson, P., & Raab‐Traub, N. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5947-7_4 · Cited by 16
Cited by
Chen, Y.-P., Chan, A. T. C., Le, Q.-T., Blanchard, P., Sun, Y., & Ma, J. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30956-0 · Cited by 3,077
Self-citationNasopharyngeal carcinoma: an evolving paradigm
Wong, K. C. W., Hui, E. P., Lo, K.-W., Lam, W. K. J., Johnson, D., Li, L., Tao, Q., Chan, K. C. A., To, K.-F., King, A. D., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00524-x · Cited by 546
Self-citationZhang, L., Huang, Y., Hong, S., Yang, Y., Yu, G., Jia, J., Peng, P., Wu, X., Lin, Q., Xi, X., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31388-5 · Cited by 522
Fang, W., Yang, Y., Ma, Y., Hong, S., Lin, L., He, X., Xiong, J., Li, P., Zhao, H., Huang, Y., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30495-9 · Cited by 489
Management of locally recurrent nasopharyngeal carcinoma
Lee, A. W. M., Ng, W. T., Chan, J. Y. W., Corry, J., Mäkitie, A., Mendenhall, W. M., Rinaldo, A., Rodrigo, J. P., Saba, N. F., Strojan, P., et al. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.101890 · Cited by 371
Self-citation
Metadata
- Authors
- Lee, A. W. M., Ma, B. B. Y., Ng, W. T., & Chan, A. T. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-10-10
- Volume
- 33
- Issue
- 29
- Pages
- 3356-3364
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2150434794
- Cited by
- 796
- References
- 52
- FWCI
- 40.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.